An update on safety and efficacy of echinocandins in antifungal therapy

Abstract

The echinocandins are important and exciting agents because of their novel mechanism of action, low incidence of serious adverse effects, and low potential for drug–drug interactions. In vitro and in vivo, the echinocandins are rapidly fungicidal against most Candida species and fungistatic against Aspergillus species.It is also a treatment option for serious fungal infections. Pharmacokinetic–pharmacodynamic studies in animals have demonstrated superior efficacy, defined as maximal microbial kill, when compared to fluconazole. Anidulafungin exhibits a unique pharmacokinetic profile, and limited cases have shown a potential for activity in isolates with increased minimum inhibitory concentrations to caspofungin and micafungin. Caspofungin appears to have a slightly higher incidence of side effects and potential for drug–drug interactions. Micafungin appears to be very similar to caspofungin, with very few obvious differences between the two agents and also have similar safety and efficacy profile in patients with fungal infections. Adverse events are generally mild, including (for caspofungin) local phlebitis, fever, abnormal liver function tests, and mild haemolysis. Anidulafungin is economical and have dominant efficacy compared with micafungin and caspofungin in patients with candidemia and/or invasive candidiasis. All three echinocandins are generally well-tolerated. Echinocandins provide safe, uncomplicated and highly active therapy for invasive Candida infections with potentially superior efficacy versus fluconazole and better tolerability compared to formulations like amphotericin B, making them the agents of choice for moderate to severely ill patients with invasive candidiasis.

Authors and Affiliations

Maryam Mahmoodan

Keywords

Related Articles

Incidence and comparative analysis of adverse drug reactions in antiretroviral therapy (highly active antiretroviral therapy, HAART)

The use of antiretroviral therapy especially use of Highly Active Antiretroviral Therapy (HAART) for HIV/AIDS patients has changed the treatment approach. The use of such therapy causes a reduction in mortality. The purp...

Drug utilization pattern of anti-diabetic drugs among type 2 diabetes mellitus patients – a prospective study

Introduction Diabetes mellitus (DM) is emerging as major health problem. There has been worldwide increase in prevalence of DM, especially in developing countries. With this increased prevalence of diabetes, drug utiliza...

Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Sebha region, Libya

Toxoplasmosis is one of the most common worldwide parasitic diseases caused by an obligate intracellular protozoan parasite Toxoplasma gondii. It is commonly transmitted to humans by accidental ingestion of oocysts voide...

Evaluation of anti-depressant activity of ethanolic extract of Verbascum thapsus in albino mice

In the present study the obtained results were compared with standard drugs and it was observed that methanolic extract produces 43.12% age yield. The Preliminary phytochemical studies were performed and chemical compone...

Carcinoma of breast with osseous metaplasia: An uncommon pathology

Metaplastic breast carcinoma is a rare breast neoplasm, and metaplastic carcinoma with osseous differentiation is even rarer. It originates from a change in the differentiation of epithelial metaplastic breast tissue cel...

Download PDF file
  • EP ID EP419175
  • DOI -
  • Views 45
  • Downloads 0

How To Cite

Maryam Mahmoodan (2017). An update on safety and efficacy of echinocandins in antifungal therapy. International Journal of Allied Medical Sciences and Clinical Research, 5(3), 716-723. https://europub.co.uk/articles/-A-419175